首页> 外文期刊>JACC. Clinical electrophysiology. >Comparative Effectiveness of Hybrid Ablation Versus Endocardial Catheter Ablation Alone in Patients With Persistent Atrial Fibrillation
【24h】

Comparative Effectiveness of Hybrid Ablation Versus Endocardial Catheter Ablation Alone in Patients With Persistent Atrial Fibrillation

机译:比较混合消融的有效性仅与心内膜的导管消融持续性房颤患者

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Objectives The outcomes of hybrid ablation versus endocardial catheter ablation alone were evaluated in patients with persistent and long-standing persistent atrial fibrillation (AF). Background Variable outcomes exist following endocardial catheter ablation in medically refractory patients with persistent AF. A hybrid epicardial?endocardial approach has emerged as an alternative to endocardial ablation. Methods In 133 consecutive patients, 69 received endocardial ablation alone (pulmonary vein isolation and radiofrequency catheter ablation [endo group]) and 64 received endocardial catheter ablation and epicardial ablation (hybrid group). Recurrence was defined as any arrhythmia following the 3-month blanking period. Results Patients were followed for a median of 16 months. The hybrid and endo groups were similar in age (61?±?10?years vs. 62 ± 8 years), body mass index (35 ± 6 kg/m 2 vs. 35 ± 7 kg/m 2 ), CHA 2 D 2 -VASc score (2 ± 1 vs. 2 ± 1), and ejection fraction (54 ± 11% vs. 53 ± 8%). The hybrid group had longer AF duration (median [interquartile range (IQR)] (12?months [IQR: 8 to 28 months] vs. 7 months [IQR: 5 to 12 months]; p? 0.001) and more previous ablations (58% vs. 25%; p? 0.001). Both groups had similar antiarrhythmic drug use at follow-up (55% vs. 48%). The hybrid group was less likely to have recurrence (37% vs. 58%; p?= 0.013) and repeat ablation (9% vs. 26%; p?= 0.012), and had an AF-free survival of 72%?versus 51% (p?= 0.01). Conclusions Among patients with persistent AF, hybrid ablation is associated with less AF recurrence and?fewer?re-do ablations. Prospective large-scale randomized trials are needed to validate these results. Graphical abstract Display Omitted
机译:抽象的目标混合的结果消融与心内膜导管消融仅在患者持续评估和长期持续性心房纤颤(AF)。心内膜导管消融后医学上耐火持续性房颤患者。混合心外膜的吗?成为一个心内膜的替代品消融。仅接受心内膜消融(肺静脉隔离和射频导管消融endo组)和64收到了心内膜的导管消融和心外膜消融(混合组)。三个月后心律失常消隐时期。中位数的16个月。相似的年龄(61±? 10 ?35年),身体质量指数(±6公斤/米2与35±7公斤/米2),CHA 2 D 2 -VASc分数(±2±1和21)、射血分数(54±11%和53±8%)。混合组房颤持续时间较长(中位数(四分位范围(差))(12 ?28个月)和7个月(IQR: 5至12个月);p ? & 比25%;抗心律失常的药物使用在随访(55% vs。48%)。复发(37% vs . 58%;消融(9% vs . 26%;AF-free生存的72% ?结论在持续性房颤患者中,混合房颤消融与少复发和更少的?大规模的随机试验需要验证这些结果。显示省略

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号